Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET Imaging of Cyclooxygenase-1 in Neuro-PASC
NCT06920628Phase 1Recruiting
- Sponsor
- National Institute of Mental Health
- Start
- Jun 2025
- Primary completion
- Feb 2028
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of [11C]PS13 in post-COVID-19 condition (PCC), sponsored by National Institute of Mental Health. Primary endpoint: Distribution volume for 11C-PS13 at 36 months. Started Jun 2025; status: recruiting.
02
Drugs
[11C]PS13
03
Conditions
post-COVID-19 condition (PCC)
Beyond the preview
Go deeper on NCT06920628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06920628.